Vara Suphapimol

Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy

Jack R Jerome, Devy Deliyanti, Varaporn Suphapimol, Peter Kolkhof, Jennifer L Wilkinson-Berka

Journal article  |  2023  |  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Vision loss in diabetic retinopathy features damage to the blood-retinal barrier and neovascularization, with hypertension and the..

ROR gamma inhibition attenuates vasculopathy in mice and rats with diabetic retinopathy by reducing Th17 cells and increasing the functionality of Tregs

Devy Deliyanti, Varaporn Suphapimol, Jennifer L Wilkinson-Berka

Conference Proceedings  |  2021  |  INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Angiotensin II and aldosterone activate retinal microglia

Indrajeetsinh Rana, Varaporn Suphapimol, Jack R Jerome, Dean M Talia, Devy Deliyanti, Jennifer L Wilkinson-Berka

Journal article  |  2020  |  EXPERIMENTAL EYE RESEARCH

Microglial cells are important contributors to the neuroinflammation and blood vessel damage that occurs in ischemic retinopathies..

Angiotensin II and aldosterone in retinal vasculopathy and inflammation

Jennifer L Wilkinson-Berka, Varaporn Suphapimol, Jack R Jerome, Devy Deliyanti, Michael J Allingham

Journal article  |  2019  |  EXPERIMENTAL EYE RESEARCH

Angiotensin II and aldosterone are the main effectors of the renin-angiotensin aldosterone system (RAAS) and have a central role i..